LEE'S PHARM (00950) Income Statement & Earnings

1.150
0.0000.00%

Not Open Apr 24 15:51 CST

677.16MMarket Cap7.37P/E (TTM)

LEE'S PHARM (00950) Income Statement

All

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q6)Jun 30, 2025

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

(Q1)Mar 31, 2022

Turnover

2.57%1.44B

5.54%694.82M

32.95%1.4B

28.51%658.35M

-14.61%1.05B

-21.08%512.31M

-2.61%1.23B

8.80%1.04B

11.15%649.17M

14.70%324.75M

Operating income

2.57%1.44B

5.54%694.82M

32.95%1.4B

28.51%658.35M

-14.61%1.05B

-21.08%512.31M

-2.61%1.23B

8.80%1.04B

11.15%649.17M

14.70%324.75M

Cost of sales

-9.25%-706.42M

-8.78%-334.77M

-28.88%-646.61M

-35.07%-307.75M

-8.51%-501.72M

0.80%-227.85M

-0.55%-462.39M

-17.88%-374.38M

-16.29%-229.69M

-20.05%-108.92M

Operating expenses

-9.25%-706.42M

-8.78%-334.77M

-28.88%-646.61M

-35.07%-307.75M

-8.51%-501.72M

0.80%-227.85M

-0.55%-462.39M

-17.88%-374.38M

-16.29%-229.69M

-20.05%-108.92M

Gross profit

-3.16%729.56M

2.70%360.05M

36.65%753.36M

23.25%350.6M

-28.47%551.31M

-32.19%284.46M

-4.41%770.76M

4.25%661.8M

8.52%419.48M

12.17%215.83M

Selling expenses

13.77%-333.98M

11.43%-152.58M

-27.27%-387.29M

-17.24%-172.27M

12.17%-304.3M

16.62%-146.93M

5.45%-346.47M

-3.96%-269.12M

-7.37%-176.22M

-12.95%-81.97M

Administrative expenses

-14.17%-222.98M

-4.68%-101.6M

-3.54%-195.3M

-7.14%-97.05M

4.94%-188.61M

18.45%-90.58M

33.25%-198.41M

21.71%-169.33M

10.57%-111.08M

2.70%-57.28M

Research and development expenses

-32.36%-110.96M

-22.11%-41.61M

13.40%-83.83M

30.17%-34.08M

42.68%-96.8M

58.15%-48.8M

30.74%-168.89M

7.53%-166.85M

-3.27%-116.59M

-28.77%-61.63M

Impairment and provision

98.83%-160K

-138.38%-472K

-970.47%-13.7M

33.11%-198K

-586.69%-1.28M

-17.00%-296K

100.29%263K

-1,196.65%-1.96M

39.62%-253K

-1,367.88%-4.18M

-Other impairment is provision

98.83%-160K

-138.38%-472K

-970.47%-13.7M

33.11%-198K

-586.69%-1.28M

-17.00%-296K

100.29%263K

-1,196.65%-1.96M

39.62%-253K

-1,367.88%-4.18M

Special items of operating profit

-38.67%24.48M

-82.38%3.72M

-52.05%39.91M

-39.99%21.13M

331.11%83.23M

-13.00%35.21M

-99.11%19.31M

-97.45%55.55M

-98.12%40.48M

-27.09%24.74M

Operating profit

-24.03%85.96M

-0.91%67.52M

159.78%113.14M

106.05%68.13M

-43.11%43.55M

-40.76%33.07M

-96.13%76.56M

-94.89%110.09M

-97.40%55.82M

-25.05%35.5M

Financing cost

20.89%-11.23M

6.41%-6.35M

-19.26%-14.19M

-24.78%-6.79M

-56.66%-11.9M

-55.44%-5.44M

-32.73%-7.6M

-23.81%-5.29M

-38.68%-3.5M

-36.66%-1.74M

Share of profits of associates

-120.14%-1.85M

-104.18%-488K

3.56%-839K

45.68%-239K

21.20%-870K

16.35%-440K

68.41%-1.1M

77.68%-753K

84.11%-526K

88.74%-255K

Earning before tax

-25.71%72.89M

-0.71%60.68M

218.70%98.11M

124.76%61.11M

-54.64%30.79M

-47.51%27.19M

-96.55%67.86M

-95.15%104.04M

-97.58%51.8M

-23.54%33.51M

Tax

24.51%-22.27M

-62.35%-10.13M

-172.25%-29.5M

0.64%-6.24M

50.80%-10.84M

74.59%-6.28M

-132.29%-22.03M

-1,841.05%-45.34M

-631.80%-24.71M

-71.85%-12.85M

After-tax profit from continuing operations

-26.23%50.62M

-7.88%50.55M

243.94%68.61M

162.42%54.87M

-56.48%19.95M

-22.79%20.91M

-97.66%45.84M

-97.26%58.7M

-98.73%27.08M

-43.16%20.67M

Earning after tax

-26.23%50.62M

-7.88%50.55M

243.94%68.61M

162.42%54.87M

-56.48%19.95M

-22.79%20.91M

-97.66%45.84M

-97.26%58.7M

-98.73%27.08M

-43.16%20.67M

Minority profit

-68.75%-41.32M

-118.68%-16.64M

-853.21%-24.49M

-258.79%-7.61M

159.66%3.25M

447.75%4.79M

80.03%-5.45M

83.43%-3.99M

93.53%-1.38M

107.63%358K

Profit attributable to shareholders

-1.25%91.94M

7.53%67.19M

457.55%93.1M

287.65%62.48M

-67.44%16.7M

-43.37%16.12M

-97.42%51.28M

-97.11%62.68M

-98.68%28.46M

-50.53%20.31M

Basic earnings per share

-1.27%0.1561

7.54%0.1141

456.69%0.1581

287.23%0.1061

-67.39%0.0284

-43.27%0.0274

-97.42%0.0871

-97.11%0.1065

-98.68%0.0483

-50.57%0.0345

Diluted earnings per share

-1.27%0.1561

7.54%0.1141

456.69%0.1581

287.23%0.1061

-67.39%0.0284

-43.27%0.0274

-97.42%0.0871

-97.11%0.1065

-98.68%0.0483

-50.50%0.0345

Currency Unit

HKD

Accounting Standards

HKAS

Audit Opinions

Unqualified Opinion

Auditor

Tianjian International Certified Public Accountants Co., Ltd.

Hengjian Accounting Firm Limited

	(FY)Dec 31, 2025	(Q6)Jun 30, 2025	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022	(Q1)Mar 31, 2022
Turnover	2.57%1.44B	5.54%694.82M	32.95%1.4B	28.51%658.35M	-14.61%1.05B	-21.08%512.31M	-2.61%1.23B	8.80%1.04B	11.15%649.17M	14.70%324.75M
Operating income	2.57%1.44B	5.54%694.82M	32.95%1.4B	28.51%658.35M	-14.61%1.05B	-21.08%512.31M	-2.61%1.23B	8.80%1.04B	11.15%649.17M	14.70%324.75M
Cost of sales	-9.25%-706.42M	-8.78%-334.77M	-28.88%-646.61M	-35.07%-307.75M	-8.51%-501.72M	0.80%-227.85M	-0.55%-462.39M	-17.88%-374.38M	-16.29%-229.69M	-20.05%-108.92M
Operating expenses	-9.25%-706.42M	-8.78%-334.77M	-28.88%-646.61M	-35.07%-307.75M	-8.51%-501.72M	0.80%-227.85M	-0.55%-462.39M	-17.88%-374.38M	-16.29%-229.69M	-20.05%-108.92M
Gross profit	-3.16%729.56M	2.70%360.05M	36.65%753.36M	23.25%350.6M	-28.47%551.31M	-32.19%284.46M	-4.41%770.76M	4.25%661.8M	8.52%419.48M	12.17%215.83M
Selling expenses	13.77%-333.98M	11.43%-152.58M	-27.27%-387.29M	-17.24%-172.27M	12.17%-304.3M	16.62%-146.93M	5.45%-346.47M	-3.96%-269.12M	-7.37%-176.22M	-12.95%-81.97M
Administrative expenses	-14.17%-222.98M	-4.68%-101.6M	-3.54%-195.3M	-7.14%-97.05M	4.94%-188.61M	18.45%-90.58M	33.25%-198.41M	21.71%-169.33M	10.57%-111.08M	2.70%-57.28M
Research and development expenses	-32.36%-110.96M	-22.11%-41.61M	13.40%-83.83M	30.17%-34.08M	42.68%-96.8M	58.15%-48.8M	30.74%-168.89M	7.53%-166.85M	-3.27%-116.59M	-28.77%-61.63M
Impairment and provision	98.83%-160K	-138.38%-472K	-970.47%-13.7M	33.11%-198K	-586.69%-1.28M	-17.00%-296K	100.29%263K	-1,196.65%-1.96M	39.62%-253K	-1,367.88%-4.18M
-Other impairment is provision	98.83%-160K	-138.38%-472K	-970.47%-13.7M	33.11%-198K	-586.69%-1.28M	-17.00%-296K	100.29%263K	-1,196.65%-1.96M	39.62%-253K	-1,367.88%-4.18M
Special items of operating profit	-38.67%24.48M	-82.38%3.72M	-52.05%39.91M	-39.99%21.13M	331.11%83.23M	-13.00%35.21M	-99.11%19.31M	-97.45%55.55M	-98.12%40.48M	-27.09%24.74M
Operating profit	-24.03%85.96M	-0.91%67.52M	159.78%113.14M	106.05%68.13M	-43.11%43.55M	-40.76%33.07M	-96.13%76.56M	-94.89%110.09M	-97.40%55.82M	-25.05%35.5M
Financing cost	20.89%-11.23M	6.41%-6.35M	-19.26%-14.19M	-24.78%-6.79M	-56.66%-11.9M	-55.44%-5.44M	-32.73%-7.6M	-23.81%-5.29M	-38.68%-3.5M	-36.66%-1.74M
Share of profits of associates	-120.14%-1.85M	-104.18%-488K	3.56%-839K	45.68%-239K	21.20%-870K	16.35%-440K	68.41%-1.1M	77.68%-753K	84.11%-526K	88.74%-255K
Earning before tax	-25.71%72.89M	-0.71%60.68M	218.70%98.11M	124.76%61.11M	-54.64%30.79M	-47.51%27.19M	-96.55%67.86M	-95.15%104.04M	-97.58%51.8M	-23.54%33.51M
Tax	24.51%-22.27M	-62.35%-10.13M	-172.25%-29.5M	0.64%-6.24M	50.80%-10.84M	74.59%-6.28M	-132.29%-22.03M	-1,841.05%-45.34M	-631.80%-24.71M	-71.85%-12.85M
After-tax profit from continuing operations	-26.23%50.62M	-7.88%50.55M	243.94%68.61M	162.42%54.87M	-56.48%19.95M	-22.79%20.91M	-97.66%45.84M	-97.26%58.7M	-98.73%27.08M	-43.16%20.67M
Earning after tax	-26.23%50.62M	-7.88%50.55M	243.94%68.61M	162.42%54.87M	-56.48%19.95M	-22.79%20.91M	-97.66%45.84M	-97.26%58.7M	-98.73%27.08M	-43.16%20.67M
Minority profit	-68.75%-41.32M	-118.68%-16.64M	-853.21%-24.49M	-258.79%-7.61M	159.66%3.25M	447.75%4.79M	80.03%-5.45M	83.43%-3.99M	93.53%-1.38M	107.63%358K
Profit attributable to shareholders	-1.25%91.94M	7.53%67.19M	457.55%93.1M	287.65%62.48M	-67.44%16.7M	-43.37%16.12M	-97.42%51.28M	-97.11%62.68M	-98.68%28.46M	-50.53%20.31M
Basic earnings per share	-1.27%0.1561	7.54%0.1141	456.69%0.1581	287.23%0.1061	-67.39%0.0284	-43.27%0.0274	-97.42%0.0871	-97.11%0.1065	-98.68%0.0483	-50.57%0.0345
Diluted earnings per share	-1.27%0.1561	7.54%0.1141	456.69%0.1581	287.23%0.1061	-67.39%0.0284	-43.27%0.0274	-97.42%0.0871	-97.11%0.1065	-98.68%0.0483	-50.50%0.0345
Currency Unit	HKD	HKD	HKD	HKD	HKD	HKD	HKD	HKD	HKD	HKD
Accounting Standards	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS
Audit Opinions	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	--	--
Auditor	Tianjian International Certified Public Accountants Co., Ltd.	--	Tianjian International Certified Public Accountants Co., Ltd.	--	Tianjian International Certified Public Accountants Co., Ltd.	--	Hengjian Accounting Firm Limited	--	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"